NAVELLIER & ASSOCIATES INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2018$290,000
-31.9%
3,765
-34.7%
0.04%
-35.6%
Q2 2018$426,000
-92.1%
5,765
-93.0%
0.06%
-92.8%
Q1 2018$5,369,000
+11.9%
82,555
+11.2%
0.81%
-9.3%
Q4 2017$4,798,000
-1.8%
74,222
-4.6%
0.90%
-5.5%
Q3 2017$4,885,000
-10.5%
77,841
-13.6%
0.95%
+16.4%
Q2 2017$5,457,000
-0.7%
90,135
-14.9%
0.82%
+1.7%
Q1 2017$5,494,000
+15.7%
105,937
-1.0%
0.80%
+2.0%
Q4 2016$4,747,000
+823.5%
107,054
+891.2%
0.78%
+975.3%
Q3 2016$514,000
-35.5%
10,800
-38.7%
0.07%
-38.7%
Q2 2016$797,000
+11.8%
17,619
+1.5%
0.12%
+28.0%
Q1 2016$713,000
+12.3%
17,352
+4.2%
0.09%
+32.9%
Q4 2015$635,000
+8.0%
16,656
-7.0%
0.07%
+18.6%
Q3 2015$588,000
-54.5%
17,907
-3.1%
0.06%
-47.8%
Q2 2015$1,293,000
+14.9%
18,483
+12.5%
0.11%
+10.8%
Q1 2015$1,125,000
+0.4%
16,423
+7.5%
0.10%
+82.1%
Q4 2014$1,120,000
+16.2%
15,284
+13.8%
0.06%
+16.7%
Q3 2014$964,000
+8.9%
13,435
+9.8%
0.05%
+20.0%
Q2 2014$885,000
+5.6%
12,235
+7.5%
0.04%
+2.6%
Q1 2014$838,000
+16.4%
11,385
+9.9%
0.04%
+21.9%
Q4 2013$720,000
+30.4%
10,357
+23.2%
0.03%
+100.0%
Q3 2013$552,000
+0.5%
8,408
+6.1%
0.02%
-38.5%
Q2 2013$549,000
+10.2%
7,926
+15.6%
0.03%
+13.0%
Q1 2013$498,000
+12.7%
6,858
+3.4%
0.02%
+4.5%
Q4 2012$442,000
+10.5%
6,6330.0%0.02%
+15.8%
Q3 2012$400,0006,6330.02%
Other shareholders
BAXTER INTL INC shareholders Q3 2015
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders